Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial. [electronic resource]
Producer: 20130521Description: 61-8 p. digitalISSN:- 1879-0844
- Adrenergic beta-Antagonists -- therapeutic use
- Aged
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Antidiuretic Hormone Receptor Antagonists
- Comorbidity
- Coronary Artery Disease -- drug therapy
- Female
- Heart Failure -- drug therapy
- Hospital Mortality -- trends
- Hospitalization
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Prognosis
- Prospective Studies
- Stroke Volume -- physiology
- Survival Rate -- trends
- United States -- epidemiology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.